Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Clinical trials Multivariety analysis). Showing records 1 – 30 of 110887 total matches.

[1] [2] [3] [4] [5] … [3697]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters


Stellenbosch University

1. Smith, Tanya. Elucidation of molecular mechanisms that may contribute to polyphenol-induced effects on neutrophil chemokinesis.

Degree: MSc, Physiological Sciences, 2017, Stellenbosch University

ENGLISH ABSTRACT: Grape-derived products are high in polyphenols and are known to have anti-oxidant and anti-inflammatory effects. In vivo studies in the context of muscle… (more)

Subjects/Keywords: Plant polyphenols; Clinical trials  – Multivariety analysis; Grape seed extract  – Grapes  – Therapeutic use; UCTD

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smith, T. (2017). Elucidation of molecular mechanisms that may contribute to polyphenol-induced effects on neutrophil chemokinesis. (Masters Thesis). Stellenbosch University. Retrieved from http://hdl.handle.net/10019.1/100953

Chicago Manual of Style (16th Edition):

Smith, Tanya. “Elucidation of molecular mechanisms that may contribute to polyphenol-induced effects on neutrophil chemokinesis.” 2017. Masters Thesis, Stellenbosch University. Accessed December 05, 2020. http://hdl.handle.net/10019.1/100953.

MLA Handbook (7th Edition):

Smith, Tanya. “Elucidation of molecular mechanisms that may contribute to polyphenol-induced effects on neutrophil chemokinesis.” 2017. Web. 05 Dec 2020.

Vancouver:

Smith T. Elucidation of molecular mechanisms that may contribute to polyphenol-induced effects on neutrophil chemokinesis. [Internet] [Masters thesis]. Stellenbosch University; 2017. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10019.1/100953.

Council of Science Editors:

Smith T. Elucidation of molecular mechanisms that may contribute to polyphenol-induced effects on neutrophil chemokinesis. [Masters Thesis]. Stellenbosch University; 2017. Available from: http://hdl.handle.net/10019.1/100953


Columbia University

2. Overbey, Jessica Ryan. Statistical Issues in Platform Trials with a Shared Control Group.

Degree: 2020, Columbia University

 Platform trials evaluating multiple treatment arms against a shared control are an efficient alternative to multiple two-arm trials. Motivated by a randomized clinical trial of… (more)

Subjects/Keywords: Biometry; Clinical trials; Clinical trials – Methodology; Multiplicity (Mathematics); Error analysis (Mathematics)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Overbey, J. R. (2020). Statistical Issues in Platform Trials with a Shared Control Group. (Doctoral Dissertation). Columbia University. Retrieved from https://doi.org/10.7916/d8-yrrr-wq26

Chicago Manual of Style (16th Edition):

Overbey, Jessica Ryan. “Statistical Issues in Platform Trials with a Shared Control Group.” 2020. Doctoral Dissertation, Columbia University. Accessed December 05, 2020. https://doi.org/10.7916/d8-yrrr-wq26.

MLA Handbook (7th Edition):

Overbey, Jessica Ryan. “Statistical Issues in Platform Trials with a Shared Control Group.” 2020. Web. 05 Dec 2020.

Vancouver:

Overbey JR. Statistical Issues in Platform Trials with a Shared Control Group. [Internet] [Doctoral dissertation]. Columbia University; 2020. [cited 2020 Dec 05]. Available from: https://doi.org/10.7916/d8-yrrr-wq26.

Council of Science Editors:

Overbey JR. Statistical Issues in Platform Trials with a Shared Control Group. [Doctoral Dissertation]. Columbia University; 2020. Available from: https://doi.org/10.7916/d8-yrrr-wq26

3. Saeed, Iman. Comparison of Methods for Handling Missing Outcome Data in Randomized Controlled Trials.

Degree: Department of Biostatistics, 2017, Brown University

 Background: Randomized clinical trials (RCTs) are considered the gold standard approach for assessing the comparative effectiveness of medical interventions. Given the importance of RCTs for… (more)

Subjects/Keywords: Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Saeed, I. (2017). Comparison of Methods for Handling Missing Outcome Data in Randomized Controlled Trials. (Thesis). Brown University. Retrieved from https://repository.library.brown.edu/studio/item/bdr:733496/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Saeed, Iman. “Comparison of Methods for Handling Missing Outcome Data in Randomized Controlled Trials.” 2017. Thesis, Brown University. Accessed December 05, 2020. https://repository.library.brown.edu/studio/item/bdr:733496/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Saeed, Iman. “Comparison of Methods for Handling Missing Outcome Data in Randomized Controlled Trials.” 2017. Web. 05 Dec 2020.

Vancouver:

Saeed I. Comparison of Methods for Handling Missing Outcome Data in Randomized Controlled Trials. [Internet] [Thesis]. Brown University; 2017. [cited 2020 Dec 05]. Available from: https://repository.library.brown.edu/studio/item/bdr:733496/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Saeed I. Comparison of Methods for Handling Missing Outcome Data in Randomized Controlled Trials. [Thesis]. Brown University; 2017. Available from: https://repository.library.brown.edu/studio/item/bdr:733496/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Rutgers University

4. Gu, Hui, 1984-. Two-stage design for phase II cancer clinical trials with multiple endpoints.

Degree: PhD, Public Health, 2017, Rutgers University

The main purpose of a single-arm phase II cancer trial of a new regimen is to determine whether it has sufficient anti-tumor activity against a… (more)

Subjects/Keywords: Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gu, Hui, 1. (2017). Two-stage design for phase II cancer clinical trials with multiple endpoints. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/55504/

Chicago Manual of Style (16th Edition):

Gu, Hui, 1984-. “Two-stage design for phase II cancer clinical trials with multiple endpoints.” 2017. Doctoral Dissertation, Rutgers University. Accessed December 05, 2020. https://rucore.libraries.rutgers.edu/rutgers-lib/55504/.

MLA Handbook (7th Edition):

Gu, Hui, 1984-. “Two-stage design for phase II cancer clinical trials with multiple endpoints.” 2017. Web. 05 Dec 2020.

Vancouver:

Gu, Hui 1. Two-stage design for phase II cancer clinical trials with multiple endpoints. [Internet] [Doctoral dissertation]. Rutgers University; 2017. [cited 2020 Dec 05]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/55504/.

Council of Science Editors:

Gu, Hui 1. Two-stage design for phase II cancer clinical trials with multiple endpoints. [Doctoral Dissertation]. Rutgers University; 2017. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/55504/


University of Missouri – Columbia

5. Zhou, Qingning. Statistical analysis of bivariate interval-censored failure time data.

Degree: 2015, University of Missouri – Columbia

 [ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Interval-censored failure time data arise when the failure time of interest in a survival… (more)

Subjects/Keywords: Failure time data analysis; Regression analysis; Censored observations (Statistics); Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhou, Q. (2015). Statistical analysis of bivariate interval-censored failure time data. (Thesis). University of Missouri – Columbia. Retrieved from http://hdl.handle.net/10355/47078

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zhou, Qingning. “Statistical analysis of bivariate interval-censored failure time data.” 2015. Thesis, University of Missouri – Columbia. Accessed December 05, 2020. http://hdl.handle.net/10355/47078.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zhou, Qingning. “Statistical analysis of bivariate interval-censored failure time data.” 2015. Web. 05 Dec 2020.

Vancouver:

Zhou Q. Statistical analysis of bivariate interval-censored failure time data. [Internet] [Thesis]. University of Missouri – Columbia; 2015. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10355/47078.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zhou Q. Statistical analysis of bivariate interval-censored failure time data. [Thesis]. University of Missouri – Columbia; 2015. Available from: http://hdl.handle.net/10355/47078

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


McMaster University

6. Pogue, Janice M. TESTING FOR TREATMENT HETEROGENEITY BETWEEN THE INDIVIDUAL OUTCOMES WITHIN A COMPOSITE OUTCOME.

Degree: PhD, 2012, McMaster University

This series of papers explores the value of and mechanisms for using a heterogeneity test to compare treatment differences between the individual outcomes included… (more)

Subjects/Keywords: composite outcomes; heterogeneity tests; clinical trials; multiple outcomes; Biostatistics; Clinical Trials; Multivariate Analysis; Statistical Methodology; Survival Analysis; Biostatistics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pogue, J. M. (2012). TESTING FOR TREATMENT HETEROGENEITY BETWEEN THE INDIVIDUAL OUTCOMES WITHIN A COMPOSITE OUTCOME. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/11860

Chicago Manual of Style (16th Edition):

Pogue, Janice M. “TESTING FOR TREATMENT HETEROGENEITY BETWEEN THE INDIVIDUAL OUTCOMES WITHIN A COMPOSITE OUTCOME.” 2012. Doctoral Dissertation, McMaster University. Accessed December 05, 2020. http://hdl.handle.net/11375/11860.

MLA Handbook (7th Edition):

Pogue, Janice M. “TESTING FOR TREATMENT HETEROGENEITY BETWEEN THE INDIVIDUAL OUTCOMES WITHIN A COMPOSITE OUTCOME.” 2012. Web. 05 Dec 2020.

Vancouver:

Pogue JM. TESTING FOR TREATMENT HETEROGENEITY BETWEEN THE INDIVIDUAL OUTCOMES WITHIN A COMPOSITE OUTCOME. [Internet] [Doctoral dissertation]. McMaster University; 2012. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/11375/11860.

Council of Science Editors:

Pogue JM. TESTING FOR TREATMENT HETEROGENEITY BETWEEN THE INDIVIDUAL OUTCOMES WITHIN A COMPOSITE OUTCOME. [Doctoral Dissertation]. McMaster University; 2012. Available from: http://hdl.handle.net/11375/11860


Penn State University

7. Foster, Krista Marie. THE ARCSINE DIFFERENCE EFFECT MEASURE IN META-ANALYSIS WITH APPLICATION TO ADVERSE EVENTS FROM LONG-ACTING BETA-AGONISTS IN ASTHMA PATIENTS .

Degree: 2011, Penn State University

 This thesis first addresses the statistical issues that are associated with the use of meta-analysis in the presence of rare events. Limitations of commonly used… (more)

Subjects/Keywords: clinical trials; binary response; arcsine difference; meta-analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Foster, K. M. (2011). THE ARCSINE DIFFERENCE EFFECT MEASURE IN META-ANALYSIS WITH APPLICATION TO ADVERSE EVENTS FROM LONG-ACTING BETA-AGONISTS IN ASTHMA PATIENTS . (Thesis). Penn State University. Retrieved from https://submit-etda.libraries.psu.edu/catalog/12357

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Foster, Krista Marie. “THE ARCSINE DIFFERENCE EFFECT MEASURE IN META-ANALYSIS WITH APPLICATION TO ADVERSE EVENTS FROM LONG-ACTING BETA-AGONISTS IN ASTHMA PATIENTS .” 2011. Thesis, Penn State University. Accessed December 05, 2020. https://submit-etda.libraries.psu.edu/catalog/12357.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Foster, Krista Marie. “THE ARCSINE DIFFERENCE EFFECT MEASURE IN META-ANALYSIS WITH APPLICATION TO ADVERSE EVENTS FROM LONG-ACTING BETA-AGONISTS IN ASTHMA PATIENTS .” 2011. Web. 05 Dec 2020.

Vancouver:

Foster KM. THE ARCSINE DIFFERENCE EFFECT MEASURE IN META-ANALYSIS WITH APPLICATION TO ADVERSE EVENTS FROM LONG-ACTING BETA-AGONISTS IN ASTHMA PATIENTS . [Internet] [Thesis]. Penn State University; 2011. [cited 2020 Dec 05]. Available from: https://submit-etda.libraries.psu.edu/catalog/12357.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Foster KM. THE ARCSINE DIFFERENCE EFFECT MEASURE IN META-ANALYSIS WITH APPLICATION TO ADVERSE EVENTS FROM LONG-ACTING BETA-AGONISTS IN ASTHMA PATIENTS . [Thesis]. Penn State University; 2011. Available from: https://submit-etda.libraries.psu.edu/catalog/12357

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queens University

8. Winch, Chad. An Investigation and Review of Futility Analysis Methods in Phase III Oncology Trials.

Degree: Community Health and Epidemiology, 2012, Queens University

 The general objective of this thesis was to improve understandings of design, conduct and analysis of randomized controlled trials (RCTs). The specific objective was to… (more)

Subjects/Keywords: Oncology ; Statistical Methods ; Randomized Clinical Trials ; Futility Analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Winch, C. (2012). An Investigation and Review of Futility Analysis Methods in Phase III Oncology Trials. (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/7689

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Winch, Chad. “An Investigation and Review of Futility Analysis Methods in Phase III Oncology Trials. ” 2012. Thesis, Queens University. Accessed December 05, 2020. http://hdl.handle.net/1974/7689.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Winch, Chad. “An Investigation and Review of Futility Analysis Methods in Phase III Oncology Trials. ” 2012. Web. 05 Dec 2020.

Vancouver:

Winch C. An Investigation and Review of Futility Analysis Methods in Phase III Oncology Trials. [Internet] [Thesis]. Queens University; 2012. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1974/7689.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Winch C. An Investigation and Review of Futility Analysis Methods in Phase III Oncology Trials. [Thesis]. Queens University; 2012. Available from: http://hdl.handle.net/1974/7689

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Bath

9. Öhrn, Carl Fredrik. Group sequential and adaptive methods : topics with applications for clinical trials.

Degree: PhD, 2011, University of Bath

 This thesis deals with sequential and adaptive methods for clinical trials, and how such methods can be used to achieve efficient clinical trial designs. The… (more)

Subjects/Keywords: 610.21; group sequential; decision analysis; Adaptive; optimality; clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Öhrn, C. F. (2011). Group sequential and adaptive methods : topics with applications for clinical trials. (Doctoral Dissertation). University of Bath. Retrieved from https://researchportal.bath.ac.uk/en/studentthesis/group-sequential-and-adaptive-methods – topics-with-applications-for-clinical-trials(0dc5888b-0e61-49d5-83c6-a5e9519982fa).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.538283

Chicago Manual of Style (16th Edition):

Öhrn, Carl Fredrik. “Group sequential and adaptive methods : topics with applications for clinical trials.” 2011. Doctoral Dissertation, University of Bath. Accessed December 05, 2020. https://researchportal.bath.ac.uk/en/studentthesis/group-sequential-and-adaptive-methods – topics-with-applications-for-clinical-trials(0dc5888b-0e61-49d5-83c6-a5e9519982fa).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.538283.

MLA Handbook (7th Edition):

Öhrn, Carl Fredrik. “Group sequential and adaptive methods : topics with applications for clinical trials.” 2011. Web. 05 Dec 2020.

Vancouver:

Öhrn CF. Group sequential and adaptive methods : topics with applications for clinical trials. [Internet] [Doctoral dissertation]. University of Bath; 2011. [cited 2020 Dec 05]. Available from: https://researchportal.bath.ac.uk/en/studentthesis/group-sequential-and-adaptive-methods – topics-with-applications-for-clinical-trials(0dc5888b-0e61-49d5-83c6-a5e9519982fa).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.538283.

Council of Science Editors:

Öhrn CF. Group sequential and adaptive methods : topics with applications for clinical trials. [Doctoral Dissertation]. University of Bath; 2011. Available from: https://researchportal.bath.ac.uk/en/studentthesis/group-sequential-and-adaptive-methods – topics-with-applications-for-clinical-trials(0dc5888b-0e61-49d5-83c6-a5e9519982fa).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.538283


University of Arizona

10. Rabe, Brooke Ann. Missing Data in Non-Inferiority Clinical Trials .

Degree: 2019, University of Arizona

 In drug, device and behavioral clinical trials, patient withdrawal, loss-to-follow-up, and non-compliance with treatment protocols complicate analysis. When the data planned for collection are compromised… (more)

Subjects/Keywords: Clinical Trials; Missing Data; Non-Inferiority; Sensitivity Analysis; Type I Error

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rabe, B. A. (2019). Missing Data in Non-Inferiority Clinical Trials . (Doctoral Dissertation). University of Arizona. Retrieved from http://hdl.handle.net/10150/634228

Chicago Manual of Style (16th Edition):

Rabe, Brooke Ann. “Missing Data in Non-Inferiority Clinical Trials .” 2019. Doctoral Dissertation, University of Arizona. Accessed December 05, 2020. http://hdl.handle.net/10150/634228.

MLA Handbook (7th Edition):

Rabe, Brooke Ann. “Missing Data in Non-Inferiority Clinical Trials .” 2019. Web. 05 Dec 2020.

Vancouver:

Rabe BA. Missing Data in Non-Inferiority Clinical Trials . [Internet] [Doctoral dissertation]. University of Arizona; 2019. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10150/634228.

Council of Science Editors:

Rabe BA. Missing Data in Non-Inferiority Clinical Trials . [Doctoral Dissertation]. University of Arizona; 2019. Available from: http://hdl.handle.net/10150/634228

11. Es, Gerrit Anne. Interim analysis in long-term clinical trials.

Degree: Department of Biostatistics, 1990, Erasmus University Medical Center

 textabstractThe purpose of this dissertation is to evaluate the usefulness of both stopping rules and estimation methods in long-term clinical trials with interim analyses. The… (more)

Subjects/Keywords: analysis; clinical trials; ASPECT trial

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Es, G. A. (1990). Interim analysis in long-term clinical trials. (Doctoral Dissertation). Erasmus University Medical Center. Retrieved from http://hdl.handle.net/1765/50822

Chicago Manual of Style (16th Edition):

Es, Gerrit Anne. “Interim analysis in long-term clinical trials.” 1990. Doctoral Dissertation, Erasmus University Medical Center. Accessed December 05, 2020. http://hdl.handle.net/1765/50822.

MLA Handbook (7th Edition):

Es, Gerrit Anne. “Interim analysis in long-term clinical trials.” 1990. Web. 05 Dec 2020.

Vancouver:

Es GA. Interim analysis in long-term clinical trials. [Internet] [Doctoral dissertation]. Erasmus University Medical Center; 1990. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1765/50822.

Council of Science Editors:

Es GA. Interim analysis in long-term clinical trials. [Doctoral Dissertation]. Erasmus University Medical Center; 1990. Available from: http://hdl.handle.net/1765/50822


Virginia Tech

12. Rojas Cordova, Alba Claudia. Resource Allocation Decision-Making in Sequential Adaptive Clinical Trials.

Degree: PhD, Industrial and Systems Engineering, 2017, Virginia Tech

 Adaptive clinical trials for new drugs or treatment options promise substantial benefits to both the pharmaceutical industry and the patients, but complicate resource allocation decisions.… (more)

Subjects/Keywords: Clinical trials; Simulation; Stochastic Dynamic Programming; Sequential Decision Analysis; Bayesian Learning

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rojas Cordova, A. C. (2017). Resource Allocation Decision-Making in Sequential Adaptive Clinical Trials. (Doctoral Dissertation). Virginia Tech. Retrieved from http://hdl.handle.net/10919/86348

Chicago Manual of Style (16th Edition):

Rojas Cordova, Alba Claudia. “Resource Allocation Decision-Making in Sequential Adaptive Clinical Trials.” 2017. Doctoral Dissertation, Virginia Tech. Accessed December 05, 2020. http://hdl.handle.net/10919/86348.

MLA Handbook (7th Edition):

Rojas Cordova, Alba Claudia. “Resource Allocation Decision-Making in Sequential Adaptive Clinical Trials.” 2017. Web. 05 Dec 2020.

Vancouver:

Rojas Cordova AC. Resource Allocation Decision-Making in Sequential Adaptive Clinical Trials. [Internet] [Doctoral dissertation]. Virginia Tech; 2017. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10919/86348.

Council of Science Editors:

Rojas Cordova AC. Resource Allocation Decision-Making in Sequential Adaptive Clinical Trials. [Doctoral Dissertation]. Virginia Tech; 2017. Available from: http://hdl.handle.net/10919/86348


McMaster University

13. Ma, Jinhui. Methodological Issues in Design and Analysis of Studies with Correlated Data in Health Research.

Degree: PhD, 2013, McMaster University

Correlated data with complex association structures arise from longitudinal studies and cluster randomized trials. However, some methodological challenges in the design and analysis of… (more)

Subjects/Keywords: longitudinal study; cluster randomized trials; correlated data; missing data; imputation; sample size calculation; Clinical Trials; Longitudinal Data Analysis and Time Series; Survival Analysis; Clinical Trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ma, J. (2013). Methodological Issues in Design and Analysis of Studies with Correlated Data in Health Research. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/12868

Chicago Manual of Style (16th Edition):

Ma, Jinhui. “Methodological Issues in Design and Analysis of Studies with Correlated Data in Health Research.” 2013. Doctoral Dissertation, McMaster University. Accessed December 05, 2020. http://hdl.handle.net/11375/12868.

MLA Handbook (7th Edition):

Ma, Jinhui. “Methodological Issues in Design and Analysis of Studies with Correlated Data in Health Research.” 2013. Web. 05 Dec 2020.

Vancouver:

Ma J. Methodological Issues in Design and Analysis of Studies with Correlated Data in Health Research. [Internet] [Doctoral dissertation]. McMaster University; 2013. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/11375/12868.

Council of Science Editors:

Ma J. Methodological Issues in Design and Analysis of Studies with Correlated Data in Health Research. [Doctoral Dissertation]. McMaster University; 2013. Available from: http://hdl.handle.net/11375/12868


University of Aberdeen

14. McPherson, Gladys. The role of minimisation in treatment allocation for clinical trials.

Degree: PhD, 2011, University of Aberdeen

 Simple randomisation is the easiest method for allocating participants to treatment groups in clinical trials. In the long run it balances all features of participants… (more)

Subjects/Keywords: 610.21; Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McPherson, G. (2011). The role of minimisation in treatment allocation for clinical trials. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=167718 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.542643

Chicago Manual of Style (16th Edition):

McPherson, Gladys. “The role of minimisation in treatment allocation for clinical trials.” 2011. Doctoral Dissertation, University of Aberdeen. Accessed December 05, 2020. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=167718 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.542643.

MLA Handbook (7th Edition):

McPherson, Gladys. “The role of minimisation in treatment allocation for clinical trials.” 2011. Web. 05 Dec 2020.

Vancouver:

McPherson G. The role of minimisation in treatment allocation for clinical trials. [Internet] [Doctoral dissertation]. University of Aberdeen; 2011. [cited 2020 Dec 05]. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=167718 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.542643.

Council of Science Editors:

McPherson G. The role of minimisation in treatment allocation for clinical trials. [Doctoral Dissertation]. University of Aberdeen; 2011. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=167718 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.542643


University of Aberdeen

15. Gardner, Heidi. Making clinical trials more efficient : consolidating, communicating and improving knowledge of participant recruitment interventions.

Degree: PhD, 2018, University of Aberdeen

 Why was the research in this thesis done? Recruitment of participants is an important part of trials, but the evidence that is available to help… (more)

Subjects/Keywords: Clinical trials; Medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gardner, H. (2018). Making clinical trials more efficient : consolidating, communicating and improving knowledge of participant recruitment interventions. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=239193 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801250

Chicago Manual of Style (16th Edition):

Gardner, Heidi. “Making clinical trials more efficient : consolidating, communicating and improving knowledge of participant recruitment interventions.” 2018. Doctoral Dissertation, University of Aberdeen. Accessed December 05, 2020. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=239193 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801250.

MLA Handbook (7th Edition):

Gardner, Heidi. “Making clinical trials more efficient : consolidating, communicating and improving knowledge of participant recruitment interventions.” 2018. Web. 05 Dec 2020.

Vancouver:

Gardner H. Making clinical trials more efficient : consolidating, communicating and improving knowledge of participant recruitment interventions. [Internet] [Doctoral dissertation]. University of Aberdeen; 2018. [cited 2020 Dec 05]. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=239193 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801250.

Council of Science Editors:

Gardner H. Making clinical trials more efficient : consolidating, communicating and improving knowledge of participant recruitment interventions. [Doctoral Dissertation]. University of Aberdeen; 2018. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=239193 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.801250


University of Missouri – Columbia

16. Duan, Ran. The nonparametric analysis of interval-censored failure time data.

Degree: 2013, University of Missouri – Columbia

 By interval-censored failure time data, we mean that the failure time of interest is observed to belong to some windows or intervals, instead of being… (more)

Subjects/Keywords: Failure time data analysis.; Survival analysis (Biometry).; Regression analysis.; Statistics.; Clinical trials  – Statistical methods.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Duan, R. (2013). The nonparametric analysis of interval-censored failure time data. (Thesis). University of Missouri – Columbia. Retrieved from https://doi.org/10.32469/10355/43236

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Duan, Ran. “The nonparametric analysis of interval-censored failure time data.” 2013. Thesis, University of Missouri – Columbia. Accessed December 05, 2020. https://doi.org/10.32469/10355/43236.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Duan, Ran. “The nonparametric analysis of interval-censored failure time data.” 2013. Web. 05 Dec 2020.

Vancouver:

Duan R. The nonparametric analysis of interval-censored failure time data. [Internet] [Thesis]. University of Missouri – Columbia; 2013. [cited 2020 Dec 05]. Available from: https://doi.org/10.32469/10355/43236.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Duan R. The nonparametric analysis of interval-censored failure time data. [Thesis]. University of Missouri – Columbia; 2013. Available from: https://doi.org/10.32469/10355/43236

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

17. Koopman, L. Pooling of Individual Patient Data from Clinical Trials. Improvement of analyses of subgroups.

Degree: 2008, Universiteit Utrecht

 Meta-analyses that use individual patient data (IPD), that is, the raw data of individual trials, rather than simply the overall results of each trial have… (more)

Subjects/Keywords: Geneeskunde; individual patient data; meta-analysis; subgroups; methods; review; clinical trials; analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Koopman, L. (2008). Pooling of Individual Patient Data from Clinical Trials. Improvement of analyses of subgroups. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/26059

Chicago Manual of Style (16th Edition):

Koopman, L. “Pooling of Individual Patient Data from Clinical Trials. Improvement of analyses of subgroups.” 2008. Doctoral Dissertation, Universiteit Utrecht. Accessed December 05, 2020. http://dspace.library.uu.nl:8080/handle/1874/26059.

MLA Handbook (7th Edition):

Koopman, L. “Pooling of Individual Patient Data from Clinical Trials. Improvement of analyses of subgroups.” 2008. Web. 05 Dec 2020.

Vancouver:

Koopman L. Pooling of Individual Patient Data from Clinical Trials. Improvement of analyses of subgroups. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2008. [cited 2020 Dec 05]. Available from: http://dspace.library.uu.nl:8080/handle/1874/26059.

Council of Science Editors:

Koopman L. Pooling of Individual Patient Data from Clinical Trials. Improvement of analyses of subgroups. [Doctoral Dissertation]. Universiteit Utrecht; 2008. Available from: http://dspace.library.uu.nl:8080/handle/1874/26059


Baylor University

18. Renfro, Lindsay A. Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials.

Degree: PhD, Statistical Sciences., 2011, Baylor University

 Surrogate endpoints are desirable in clinical trials when primary endpoints are costly to obtain, difficult to measure, or require lengthy follow-up to observe. Despite legitimate… (more)

Subjects/Keywords: Biostatistics.; Survival analysis.; Bayesian adaptive design.; Clinical trials.; Flowgraph analysis.; Surrogate endpoints.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Renfro, L. A. (2011). Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials. (Doctoral Dissertation). Baylor University. Retrieved from http://hdl.handle.net/2104/8165

Chicago Manual of Style (16th Edition):

Renfro, Lindsay A. “Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials.” 2011. Doctoral Dissertation, Baylor University. Accessed December 05, 2020. http://hdl.handle.net/2104/8165.

MLA Handbook (7th Edition):

Renfro, Lindsay A. “Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials.” 2011. Web. 05 Dec 2020.

Vancouver:

Renfro LA. Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials. [Internet] [Doctoral dissertation]. Baylor University; 2011. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2104/8165.

Council of Science Editors:

Renfro LA. Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials. [Doctoral Dissertation]. Baylor University; 2011. Available from: http://hdl.handle.net/2104/8165


University of Missouri – Kansas City

19. Krishnamoorthy, Saranya. A data driven semantic framework for clinical trial eligibility criteria.

Degree: 2012, University of Missouri – Kansas City

 An important step in the discovery of new treatments for medical conditions is the matching of potential subjects with appropriate clinical trials. Eligibility criteria for… (more)

Subjects/Keywords: Clinical trials; Cluster analysis; Thesis  – University of Missouri – Kansas City  – Computer science

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Krishnamoorthy, S. (2012). A data driven semantic framework for clinical trial eligibility criteria. (Thesis). University of Missouri – Kansas City. Retrieved from http://hdl.handle.net/10355/12463

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Krishnamoorthy, Saranya. “A data driven semantic framework for clinical trial eligibility criteria.” 2012. Thesis, University of Missouri – Kansas City. Accessed December 05, 2020. http://hdl.handle.net/10355/12463.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Krishnamoorthy, Saranya. “A data driven semantic framework for clinical trial eligibility criteria.” 2012. Web. 05 Dec 2020.

Vancouver:

Krishnamoorthy S. A data driven semantic framework for clinical trial eligibility criteria. [Internet] [Thesis]. University of Missouri – Kansas City; 2012. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10355/12463.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Krishnamoorthy S. A data driven semantic framework for clinical trial eligibility criteria. [Thesis]. University of Missouri – Kansas City; 2012. Available from: http://hdl.handle.net/10355/12463

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

20. Marange, Chioneso Show. Maximization of power in randomized clinical trials using the minimization treatment allocation technique.

Degree: MS, Biostatistics and epidemiology, 2010, University of Fort Hare

 Generally the primary goal of randomized clinical trials (RCT) is to make comparisons among two or more treatments hence clinical investigators require the most appropriate… (more)

Subjects/Keywords: Clinical trials  – Statistical methods; Statistical hypothesis testing; Regression analysis; Logistic distribution; Estimation theory

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Marange, C. S. (2010). Maximization of power in randomized clinical trials using the minimization treatment allocation technique. (Masters Thesis). University of Fort Hare. Retrieved from http://hdl.handle.net/10353/399

Chicago Manual of Style (16th Edition):

Marange, Chioneso Show. “Maximization of power in randomized clinical trials using the minimization treatment allocation technique.” 2010. Masters Thesis, University of Fort Hare. Accessed December 05, 2020. http://hdl.handle.net/10353/399.

MLA Handbook (7th Edition):

Marange, Chioneso Show. “Maximization of power in randomized clinical trials using the minimization treatment allocation technique.” 2010. Web. 05 Dec 2020.

Vancouver:

Marange CS. Maximization of power in randomized clinical trials using the minimization treatment allocation technique. [Internet] [Masters thesis]. University of Fort Hare; 2010. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10353/399.

Council of Science Editors:

Marange CS. Maximization of power in randomized clinical trials using the minimization treatment allocation technique. [Masters Thesis]. University of Fort Hare; 2010. Available from: http://hdl.handle.net/10353/399


University of Tasmania

21. Murphy, LM. The value of clinical trials : a New Zealand case study.

Degree: 2012, University of Tasmania

 Objective: The research question addressed in this thesis is - ‘What is the value of conducting sponsored clinical trials in a publicly funded New Zealand… (more)

Subjects/Keywords: health value; clinical trials; cost benefit analysis; mixed method; stakeholder; public perception

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Murphy, L. (2012). The value of clinical trials : a New Zealand case study. (Thesis). University of Tasmania. Retrieved from https://eprints.utas.edu.au/14684/2/whole-murphy-thesis-2012.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Murphy, LM. “The value of clinical trials : a New Zealand case study.” 2012. Thesis, University of Tasmania. Accessed December 05, 2020. https://eprints.utas.edu.au/14684/2/whole-murphy-thesis-2012.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Murphy, LM. “The value of clinical trials : a New Zealand case study.” 2012. Web. 05 Dec 2020.

Vancouver:

Murphy L. The value of clinical trials : a New Zealand case study. [Internet] [Thesis]. University of Tasmania; 2012. [cited 2020 Dec 05]. Available from: https://eprints.utas.edu.au/14684/2/whole-murphy-thesis-2012.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Murphy L. The value of clinical trials : a New Zealand case study. [Thesis]. University of Tasmania; 2012. Available from: https://eprints.utas.edu.au/14684/2/whole-murphy-thesis-2012.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Iowa

22. Lou, Yiyue. Principal stratification : applications and extensions in clinical trials with intermediate variables.

Degree: PhD, Biostatistics, 2017, University of Iowa

  Randomized clinical trials (RCTs) are considered to be the "gold standard" in order to demonstrate a causal relationship between a treatment and an outcome… (more)

Subjects/Keywords: Bioequivalence; Causal Inference; Clinical Trials; Intermediate Variable; Principal Stratification; Sensitivity analysis; Biostatistics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lou, Y. (2017). Principal stratification : applications and extensions in clinical trials with intermediate variables. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/5961

Chicago Manual of Style (16th Edition):

Lou, Yiyue. “Principal stratification : applications and extensions in clinical trials with intermediate variables.” 2017. Doctoral Dissertation, University of Iowa. Accessed December 05, 2020. https://ir.uiowa.edu/etd/5961.

MLA Handbook (7th Edition):

Lou, Yiyue. “Principal stratification : applications and extensions in clinical trials with intermediate variables.” 2017. Web. 05 Dec 2020.

Vancouver:

Lou Y. Principal stratification : applications and extensions in clinical trials with intermediate variables. [Internet] [Doctoral dissertation]. University of Iowa; 2017. [cited 2020 Dec 05]. Available from: https://ir.uiowa.edu/etd/5961.

Council of Science Editors:

Lou Y. Principal stratification : applications and extensions in clinical trials with intermediate variables. [Doctoral Dissertation]. University of Iowa; 2017. Available from: https://ir.uiowa.edu/etd/5961


University of Toronto

23. Tian, Yu. What are the best treatments for proliferative lupus nephritis?.

Degree: PhD, 2018, University of Toronto

 Background. Trial evidence, in adults, examining the relative effectiveness of immunosuppressive agents in the treatment of proliferative lupus nephritis (PLN) has been controversial. Trial evidence… (more)

Subjects/Keywords: Bayesian analysis; causal inference; clinical trials; immunosuppressive treatment; lupus nephritis; metaanalysis; 0566

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tian, Y. (2018). What are the best treatments for proliferative lupus nephritis?. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/89739

Chicago Manual of Style (16th Edition):

Tian, Yu. “What are the best treatments for proliferative lupus nephritis?.” 2018. Doctoral Dissertation, University of Toronto. Accessed December 05, 2020. http://hdl.handle.net/1807/89739.

MLA Handbook (7th Edition):

Tian, Yu. “What are the best treatments for proliferative lupus nephritis?.” 2018. Web. 05 Dec 2020.

Vancouver:

Tian Y. What are the best treatments for proliferative lupus nephritis?. [Internet] [Doctoral dissertation]. University of Toronto; 2018. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/1807/89739.

Council of Science Editors:

Tian Y. What are the best treatments for proliferative lupus nephritis?. [Doctoral Dissertation]. University of Toronto; 2018. Available from: http://hdl.handle.net/1807/89739


University of Minnesota

24. Lian, Qinshu. Statistical methods for multivariate meta-analysis.

Degree: PhD, Biostatistics, 2018, University of Minnesota

 As health problems get more complicated, the medical decisions and policies are rarely determined by evidence on a single effect. In recent years, there is… (more)

Subjects/Keywords: Bayesian hierarchical models; Clinical trials; Diagnostic tests; Misclassification; Missing data; Network meta-analysis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lian, Q. (2018). Statistical methods for multivariate meta-analysis. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/200307

Chicago Manual of Style (16th Edition):

Lian, Qinshu. “Statistical methods for multivariate meta-analysis.” 2018. Doctoral Dissertation, University of Minnesota. Accessed December 05, 2020. http://hdl.handle.net/11299/200307.

MLA Handbook (7th Edition):

Lian, Qinshu. “Statistical methods for multivariate meta-analysis.” 2018. Web. 05 Dec 2020.

Vancouver:

Lian Q. Statistical methods for multivariate meta-analysis. [Internet] [Doctoral dissertation]. University of Minnesota; 2018. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/11299/200307.

Council of Science Editors:

Lian Q. Statistical methods for multivariate meta-analysis. [Doctoral Dissertation]. University of Minnesota; 2018. Available from: http://hdl.handle.net/11299/200307


University of Hong Kong

25. Teh, Jun-chuan. Globalisation of sponsored clinical trials ten years after the introduction of ICH GCP.

Degree: 2007, University of Hong Kong

Subjects/Keywords: Clinical trials.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Teh, J. (2007). Globalisation of sponsored clinical trials ten years after the introduction of ICH GCP. (Thesis). University of Hong Kong. Retrieved from http://hdl.handle.net/10722/50768

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Teh, Jun-chuan. “Globalisation of sponsored clinical trials ten years after the introduction of ICH GCP.” 2007. Thesis, University of Hong Kong. Accessed December 05, 2020. http://hdl.handle.net/10722/50768.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Teh, Jun-chuan. “Globalisation of sponsored clinical trials ten years after the introduction of ICH GCP.” 2007. Web. 05 Dec 2020.

Vancouver:

Teh J. Globalisation of sponsored clinical trials ten years after the introduction of ICH GCP. [Internet] [Thesis]. University of Hong Kong; 2007. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/10722/50768.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Teh J. Globalisation of sponsored clinical trials ten years after the introduction of ICH GCP. [Thesis]. University of Hong Kong; 2007. Available from: http://hdl.handle.net/10722/50768

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Wollongong

26. Jameson, Michael Geoffrey. Hitting the target: analysis of delineation and dosimetric uncertainty in radiotherapy.

Degree: PhD, 2015, University of Wollongong

  Through advances in radiation delivery systems and image guidance, the accuracy and precision of radiation therapy has improved in recent times. Some aspects with… (more)

Subjects/Keywords: radiotherapy; uncertainty; contouring; clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jameson, M. G. (2015). Hitting the target: analysis of delineation and dosimetric uncertainty in radiotherapy. (Doctoral Dissertation). University of Wollongong. Retrieved from 0299 OTHER PHYSICAL SCIENCES, 1103 CLINICAL SCIENCES, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/4607

Chicago Manual of Style (16th Edition):

Jameson, Michael Geoffrey. “Hitting the target: analysis of delineation and dosimetric uncertainty in radiotherapy.” 2015. Doctoral Dissertation, University of Wollongong. Accessed December 05, 2020. 0299 OTHER PHYSICAL SCIENCES, 1103 CLINICAL SCIENCES, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/4607.

MLA Handbook (7th Edition):

Jameson, Michael Geoffrey. “Hitting the target: analysis of delineation and dosimetric uncertainty in radiotherapy.” 2015. Web. 05 Dec 2020.

Vancouver:

Jameson MG. Hitting the target: analysis of delineation and dosimetric uncertainty in radiotherapy. [Internet] [Doctoral dissertation]. University of Wollongong; 2015. [cited 2020 Dec 05]. Available from: 0299 OTHER PHYSICAL SCIENCES, 1103 CLINICAL SCIENCES, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/4607.

Council of Science Editors:

Jameson MG. Hitting the target: analysis of delineation and dosimetric uncertainty in radiotherapy. [Doctoral Dissertation]. University of Wollongong; 2015. Available from: 0299 OTHER PHYSICAL SCIENCES, 1103 CLINICAL SCIENCES, 1112 ONCOLOGY AND CARCINOGENESIS ; https://ro.uow.edu.au/theses/4607


University of Aberdeen

27. McGhee, David J. M. Improving clinical trial design in neurodegenerative disorders.

Degree: PhD, 2014, University of Aberdeen

 This thesis aimed to improve the methodology of disease-modification clinical trials in neurodegenerative disorders, with particular reference to Parkinson's disease (PD) and Alzheimer's disease. A… (more)

Subjects/Keywords: 616.8; Nervous system; Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McGhee, D. J. M. (2014). Improving clinical trial design in neurodegenerative disorders. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=225325 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641459

Chicago Manual of Style (16th Edition):

McGhee, David J M. “Improving clinical trial design in neurodegenerative disorders.” 2014. Doctoral Dissertation, University of Aberdeen. Accessed December 05, 2020. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=225325 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641459.

MLA Handbook (7th Edition):

McGhee, David J M. “Improving clinical trial design in neurodegenerative disorders.” 2014. Web. 05 Dec 2020.

Vancouver:

McGhee DJM. Improving clinical trial design in neurodegenerative disorders. [Internet] [Doctoral dissertation]. University of Aberdeen; 2014. [cited 2020 Dec 05]. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=225325 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641459.

Council of Science Editors:

McGhee DJM. Improving clinical trial design in neurodegenerative disorders. [Doctoral Dissertation]. University of Aberdeen; 2014. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?pid=225325 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.641459


Queen Mary, University of London

28. Yeung, Wai Yin. Inference following biased coin designs in clinical trials.

Degree: PhD, 2013, Queen Mary, University of London

 Randomization schemes for two-treatment clinical trials are studied. Theoretical expressions for the power are derived under both complete randomization and Efron’s biased coin design for… (more)

Subjects/Keywords: 615.5072; Mathematics; Clinical Trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yeung, W. Y. (2013). Inference following biased coin designs in clinical trials. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8713 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.633493

Chicago Manual of Style (16th Edition):

Yeung, Wai Yin. “Inference following biased coin designs in clinical trials.” 2013. Doctoral Dissertation, Queen Mary, University of London. Accessed December 05, 2020. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8713 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.633493.

MLA Handbook (7th Edition):

Yeung, Wai Yin. “Inference following biased coin designs in clinical trials.” 2013. Web. 05 Dec 2020.

Vancouver:

Yeung WY. Inference following biased coin designs in clinical trials. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2013. [cited 2020 Dec 05]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8713 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.633493.

Council of Science Editors:

Yeung WY. Inference following biased coin designs in clinical trials. [Doctoral Dissertation]. Queen Mary, University of London; 2013. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8713 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.633493


Boston University

29. Leatherman, Sarah Michelle. Adaptive methods for Bayesian time-to-event point-of-care clinical trials.

Degree: PhD, Biostatistics, 2014, Boston University

 Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design features. The goal is to integrate research into standard care such that the… (more)

Subjects/Keywords: Biostatistics; Bayesian; Adaptive; Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leatherman, S. M. (2014). Adaptive methods for Bayesian time-to-event point-of-care clinical trials. (Doctoral Dissertation). Boston University. Retrieved from http://hdl.handle.net/2144/14317

Chicago Manual of Style (16th Edition):

Leatherman, Sarah Michelle. “Adaptive methods for Bayesian time-to-event point-of-care clinical trials.” 2014. Doctoral Dissertation, Boston University. Accessed December 05, 2020. http://hdl.handle.net/2144/14317.

MLA Handbook (7th Edition):

Leatherman, Sarah Michelle. “Adaptive methods for Bayesian time-to-event point-of-care clinical trials.” 2014. Web. 05 Dec 2020.

Vancouver:

Leatherman SM. Adaptive methods for Bayesian time-to-event point-of-care clinical trials. [Internet] [Doctoral dissertation]. Boston University; 2014. [cited 2020 Dec 05]. Available from: http://hdl.handle.net/2144/14317.

Council of Science Editors:

Leatherman SM. Adaptive methods for Bayesian time-to-event point-of-care clinical trials. [Doctoral Dissertation]. Boston University; 2014. Available from: http://hdl.handle.net/2144/14317


University of Aberdeen

30. McPherson, Gladys. The role of minimisation in treatment allocation for clinical trials.

Degree: School of Medicine and Dentistry., 2011, University of Aberdeen

Subjects/Keywords: Clinical trials

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McPherson, G. (2011). The role of minimisation in treatment allocation for clinical trials. (Doctoral Dissertation). University of Aberdeen. Retrieved from http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=167718 ; http://digitool.abdn.ac.uk:1801/webclient/DeliveryManager?pid=167718&custom_att_2=simple_viewer

Chicago Manual of Style (16th Edition):

McPherson, Gladys. “The role of minimisation in treatment allocation for clinical trials.” 2011. Doctoral Dissertation, University of Aberdeen. Accessed December 05, 2020. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=167718 ; http://digitool.abdn.ac.uk:1801/webclient/DeliveryManager?pid=167718&custom_att_2=simple_viewer.

MLA Handbook (7th Edition):

McPherson, Gladys. “The role of minimisation in treatment allocation for clinical trials.” 2011. Web. 05 Dec 2020.

Vancouver:

McPherson G. The role of minimisation in treatment allocation for clinical trials. [Internet] [Doctoral dissertation]. University of Aberdeen; 2011. [cited 2020 Dec 05]. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=167718 ; http://digitool.abdn.ac.uk:1801/webclient/DeliveryManager?pid=167718&custom_att_2=simple_viewer.

Council of Science Editors:

McPherson G. The role of minimisation in treatment allocation for clinical trials. [Doctoral Dissertation]. University of Aberdeen; 2011. Available from: http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=167718 ; http://digitool.abdn.ac.uk:1801/webclient/DeliveryManager?pid=167718&custom_att_2=simple_viewer

[1] [2] [3] [4] [5] … [3697]

.